Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincenzo Pasceri

Showing results (1-10 of 121) with videos related to

Pageof 13
Sort By:
The New England Journal of Medicine|December 30, 2006
Enoxaparin in elective percutaneous coronary interventionVincenzo Pasceri
Lancet (London, England)|August 21, 2007
Coronary restenosis: a new strategy for the future?Francesco Pelliccia, Vincenzo Pasceri
JAMA|June 17, 2004
C-reactive protein and risk of colon cancerVincenzo Pasceri, Giovanni Cammarota
International Journal of Cardiology|April 4, 2021
The less-is-better effect: The case of alcohol dose in septal ablation for hypertrophic cardiomyopathyFrancesco Pelliccia, Vincenzo Pasceri
Journal of the American College of Cardiology|May 10, 2006
Limitations of crush techniqueChristian Pristipino, Vincenzo Pasceri, Giuseppe Richichi
The New England Journal of Medicine|April 6, 2018
PCI Strategies in Acute Myocardial Infarction with Cardiogenic ShockVincenzo Pasceri, Francesco Pelliccia, Giulio Speciale
European Journal of Internal Medicine|November 10, 2019
Contributors to survival benefit of dual versus single antithrombotic therapy in chronic coronary syndrome: Survival benefit of dual antithrombotic therapy in CCSGiuseppe Patti, Alessandro Sticchi, Vincenzo Pasceri
European Heart Journal|January 11, 2005
Statins and percutaneous coronary interventionVincenzo Pasceri, Giuseppe Patti, Germano Di Sciascio
The New England Journal of Medicine|March 22, 2008
Prasugrel versus clopidogrelVincenzo Pasceri, Giuseppe Patti, Germano Di Sciascio
Cardiovascular & Hematological Disorders Drug Targets|June 22, 2006
Prevention of myocardial damage during coronary interventionVincenzo Pasceri, Giuseppe Patti, Germano Di Sciascio
Pageof 13

Showing results (1-10 of 121) with videos related to

Sort By:
Pageof 13
The New England Journal of Medicine|December 30, 2006
Enoxaparin in elective percutaneous coronary interventionVincenzo Pasceri
Lancet (London, England)|August 21, 2007
Coronary restenosis: a new strategy for the future?Francesco Pelliccia, Vincenzo Pasceri
JAMA|June 17, 2004
C-reactive protein and risk of colon cancerVincenzo Pasceri, Giovanni Cammarota
International Journal of Cardiology|April 4, 2021
The less-is-better effect: The case of alcohol dose in septal ablation for hypertrophic cardiomyopathyFrancesco Pelliccia, Vincenzo Pasceri
Journal of the American College of Cardiology|May 10, 2006
Limitations of crush techniqueChristian Pristipino, Vincenzo Pasceri, Giuseppe Richichi
The New England Journal of Medicine|April 6, 2018
PCI Strategies in Acute Myocardial Infarction with Cardiogenic ShockVincenzo Pasceri, Francesco Pelliccia, Giulio Speciale
European Journal of Internal Medicine|November 10, 2019
Contributors to survival benefit of dual versus single antithrombotic therapy in chronic coronary syndrome: Survival benefit of dual antithrombotic therapy in CCSGiuseppe Patti, Alessandro Sticchi, Vincenzo Pasceri
European Heart Journal|January 11, 2005
Statins and percutaneous coronary interventionVincenzo Pasceri, Giuseppe Patti, Germano Di Sciascio
The New England Journal of Medicine|March 22, 2008
Prasugrel versus clopidogrelVincenzo Pasceri, Giuseppe Patti, Germano Di Sciascio
Cardiovascular & Hematological Disorders Drug Targets|June 22, 2006
Prevention of myocardial damage during coronary interventionVincenzo Pasceri, Giuseppe Patti, Germano Di Sciascio
Pageof 13